The US Representative Peter Meijer (R-MI) recently introduced a non-partisan bicameral law that is intended to authorize the US Department of Veterans (VA) to conduct clinical research studies on medical cannabis.
“Veterans across the country continue to experience chronic pain and PTSD from their ministry, and too many are lost here at home to opioid overdoses and suicide,” said Rep. Meijer. “We owe it to our nation’s veterans to seek alternative treatment that could be safer and more effective.”
In particular the VA Medicinal Cannabis Research Act of 2021, HR 2916, the Rep. Meijer on April 30th together with the bill sponsor US-Rep. Luis Correa (D-CA) would instruct the VA secretary to conduct a series of clinical studies, according to The Effects of Cannabis on Certain Health Outcomes for U.S. Military Veterans Diagnosed with Post-Traumatic Stress Disorder (PTSD) and Chronic Pain the text of the bill.
Accompanying Bill p. 1467 was introduced on April 29th by Senate Veterans Committee Chairman Jon Tester (D-MT) and US Senator Dan Sullivan (R-AK).
If effective, the measure would direct the VA to conduct scientific and medical studies on the safety and efficacy of medical cannabis use by veterans and to submit a report to Congress outlining its plan to conduct research and report on results and progress during the regular Implementation of the project is set out according to an invoice summary provided by Rep. Meijer’s office.
“There is still a need for increased research and studies into cannabis as an alternative treatment,” said Rep. Meijer, “and this bill will help the VA move these studies forward.”